1426 studies found for:    rituximab
Show Display Options
Rank Status Study
1 Terminated
Has Results
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia
Conditions: Leukemia;   Acute Lymphoblastic Leukemia;   ALL
Intervention: Drug: rituximab
2 Recruiting PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: CT-P10;   Drug: Rituxan;   Drug: MabThera
3 Completed Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab
Conditions: Humoral Acute Refection of Renal Transplant;   Autoimmune Diseases
Interventions: Drug: Rituximab 375;   Drug: rituximab 1000
4 Recruiting To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
Condition: Lymphoma, Follicular
Interventions: Biological: rituximab;   Biological: CT-P10
5 Unknown  Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Interventions: Drug: lenalidomide-low dose dexamethasone plus rituximab;   Drug: Lenalidomide + Rituximab
6 Withdrawn Rituximab for GVHD
Conditions: Graft vs Host Disease;   Alogenic Hematopoietic Transplant
Intervention: Drug: Rituximab
7 Recruiting A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Lenalidomide;   Drug: Rituximab - CHOP;   Drug: Rituximab - CVP;   Drug: Rituximab - Bendamustine
8 Recruiting Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
Condition: Pemphigus Disease
Intervention: Drug: General Corticotherapy
9 Recruiting Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus
Condition: Pemphigus
Intervention: Drug: Rituximab and Cyclophosphamide IV
10 Active, not recruiting Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Novantrone;   Drug: Decadron;   Drug: Rituximab;   Drug: Interferon;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Ara-C;   Drug: Methyl-Prednisolone;   Drug: Procarbazine;   Drug: Prednisone
11 Terminated Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
Conditions: Grafting;   Renal Transplantation;   Transplantation, Kidney;   Chronic Allograft Nephropathy
Intervention: Drug: MabThera
12 Recruiting Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Condition: Lymphoma, Non-Hodgkin
Interventions: Drug: Lenalidomide;   Drug: Rituximab
13 Completed Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
Conditions: Diffuse Large Cell Lymphoma;   Lymphoma
Interventions: Drug: Zevalin;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Drug: Rituximab;   Procedure: Stem Cell Transplant
14 Recruiting Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid
Condition: Bullous Pemphigoid
Intervention: Drug: Mabthera
15 Completed
Has Results
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Conditions: Anemia, Aplastic;   Red-Cell Aplasia, Pure;   Anemia, Diamond-Blackfan
Intervention: Drug: Rituximab
16 Recruiting R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL
Condition: Mantle Cell Lymphoma
Interventions: Drug: R-CHOP;   Drug: R-CHOP / R-HAD;   Drug: Rituximab;   Drug: Lenalidomide
17 Active, not recruiting Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: Everolimus;   Drug: Rituximab;   Drug: Bortezomib
18 Completed A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
Condition: Refractory Myasthenia Gravis
Intervention: Drug: Rituximab (Rituxan)
19 Active, not recruiting A Study of MabThera (Rituximab) Subcutaneous Vs. MabThera (Rituximab) Intravenous in Patients With Follicular Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Mabthera intravenous;   Drug: MabThera subcutaneous
20 Not yet recruiting Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy
Condition: Posttransplant Lymphoproliferative Disorder
Interventions: Drug: Rituximab sc;   Drug: Rituximab sc consolidation;   Drug: Rituximab sc combined with CHOP chemotherapy;   Drug: Rituximab sc combined with alternating chemotherapy with CHOP and DHAOx

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years